Robert Whitfield MD describes SHARP, a clinical approach for breast implant illness that combines broad testing for mold mycotoxins with pre-surgical detoxification. He notes that autoimmune diagnoses often appear after implant exposure, using a bucket analogy to explain how toxins accumulate.
I mean, somebody's just saying, like, I don't feel well. How do you determine that breast implant illness is what a woman has?
We created a methodology called Sharp, and it's really just to look at all that testing plus create a detoxification program for them. And it can be used for any type of surgery because, you know, anybody is exposed to multiple things daily, monthly, throughout their life, they're going to build up a certain amount of toxicity. Your body's going to be able to handle a certain amount of it. But, you know, the joke is, like, when the bucket's full, the bucket runs over. And that's how my patients are now. And it could be anything. They could get exposed to mold. They could have a traumatic event in the family. Somebody passes away.
You have a list that you run through before the surgery to, like, basically eliminate any possibility that it's not breast implant analysis. Like your checking for mold. You're checking. Is that what you're saying? This detoxification happens before the surgery?
Yeah. The tox test is actually. It looks at mold toxins. Mold is a big problem.
Huge.
It's not easy. And if you don't know what's going on and you continually get exposed, it's going to have significant impact on your health.
Are most people with breast implant illness, are they diagnosed with an autoimmune disease before and then chose to get breast implants anyway, or are the autoimmune diseases popping up after the breast implants?
Yeah, it's the latter. They're told they're developing some kind of autoimmune disease.
Okay.
